Related Experiment Video
Updated: May 25, 2026
07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Inflammation, DNA methylation and colitis-associated cancer
Lori Hartnett1, Laurence J Egan
1Department of Pharmacology and Therapeutics, National University of Ireland, Galway, Ireland.
Carcinogenesis
|January 12, 2012
Summary
Chronic inflammation, often seen in inflammatory bowel disease (IBD), significantly increases colorectal cancer risk. Epigenetic changes, like DNA methylation alterations, play a key role in this inflammation-associated cancer development.
Area of Science:
- Gastroenterology
- Oncology
- Immunology
Background:
- Chronic inflammation is linked to increased cancer risk, particularly in the gastrointestinal tract.
- Inflammatory bowel disease (IBD) patients face a 2-3x higher risk of colorectal cancer.
- Colitis-associated cancer (CAC) development is complex, involving genetic and epigenetic factors.
Purpose of the Study:
- To review the role of epigenetic alterations, specifically DNA methylation, in inflammation-associated carcinogenesis.
- To discuss the impact of these epigenetic changes on gene expression and epithelial cell transformation in IBD and CAC.
- To highlight recent technological advances and therapeutic potential in understanding these mechanisms.
Main Methods:
- Review of existing literature on inflammation, epigenetics, and cancer.
- Focus on DNA methylation as a key epigenetic mechanism.
- Discussion of technological advancements in genome-wide DNA methylation analysis.
Main Results:
- Sustained inflammatory responses can distort immune functions, promoting cancer development.
- Epigenetic alterations, particularly DNA methylation changes, are observed during inflammation and carcinogenesis.
- These methylation changes affect gene expression, contributing to malignant transformation in IBD-associated cancers.
Conclusions:
- A strong link exists between chronic inflammation and cancer, especially colorectal cancer in IBD patients.
- Epigenetic modifications, such as DNA methylation, are crucial mediators in the development of colitis-associated cancer.
- Understanding these molecular mechanisms offers potential therapeutic strategies for preventing or treating inflammation-driven cancers.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:37Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...